International collaboration meets in Vietnam to facilitate treatment recommendation guidelines that help people with cancer to live better lives.
Nov 1, 2024
SHANGHAI,Nov. 1,2024-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors,
Nov 1, 2024
Hong Kong Animation Once Again Stands Out Across Asia Morph Workshop Won DigiCon6 ASIA Best Story Award
Oct 31, 2024
SINGAPORE,Oct. 30,2024--Teijin Limited and Hilleman Laboratories,a biotechnology company based in Singapore,announced today the signing of a Memorandum of Understanding,for the establishment of a stra
Oct 31, 2024
HO CHI MINH CITY,Vietnam,Oct. 29,2024-- TheMMA Vietnam Impact 2024,held on October 25 at JW Marriott Saigon,marked a milestone for MMA Global\'s 13th year in Vietnam,drawing over 1,500 top leaders and
Oct 31, 2024
DUBAI,UAE,Oct. 30,2024-- Nakheel,a member of Dubai Holding\'s pioneering real estate arm,Dubai Holding Real Estate,has partnered with Dubai Electricity and Water Authority(DEWA) on the development of
Oct 31, 2024
SINGAPORE,Oct. 30,2024--MoneySmart Group,Southeast Asia\'s leading personal finance group,is proud to celebrate 15 years of empowering individuals and families to make smarter financial decisions thro
Oct 31, 2024
EXCLUSIVE PRE-SALE TICKET OPPORTUNITY 5-7 NOVEMBER 2024 TICKETS OPEN TO GENERAL PUBLIC STARTING 8 NOVEMBER 2024
Oct 31, 2024
SINGAPORE,Oct. 30,2024--Caravelle International Group(NASDAQ: HTCO),a global ocean technology company,today announced the appointment of Jinyu Chang as Chairman of the Board of Directors and XinHe as
Oct 31, 2024
Neurophet enters into a strategic agreement with LADO to distribute Neurophet SCALE PET Improves the efficiency of market entry with expertise of medical device go-to-market process in China through
Oct 31, 2024
BEIJING,Oct. 30,2024--Recon Technology,Ltd (NASDAQ: RCON) ("Recon" or the "Company"),a China-based independent solutions integrator in the oilfield service and environmental protec
Oct 31, 2024
HONG KONG,Oct. 31,2024--Akeso Biopharma (9926.HK) is pleased to announce the enrollment of the first patient in its randomized,controlled,multicenter Phase III clinical study (AK117-302) for head and
Oct 31, 2024
© Singapore Technology Information Privacy Policy Contact us